Jaekyu Shin
Overview
Explore the profile of Jaekyu Shin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamraz B, Shin J, Khanna R, Van Ziffle J, Knowles S, Stregowski S, et al.
J Am Med Inform Assoc
. 2024 Dec;
32(3):566-571.
PMID: 39665424
Objective: This article describes the implementation of preemptive clinical pharmacogenomics (PGx) testing linked to an automated clinical decision support (CDS) system delivering actionable PGx information to clinicians at the point...
2.
Jung M, Lee B, Lee S, Shin J
Ann Pharmacother
. 2024 Mar;
58(12):1193-1203.
PMID: 38506414
Background: While moderate-intensity statin therapy is recommended for primary prevention, statins may not be utilized at a recommended intensity due to dose-dependent adverse events, especially in an Asian population. However,...
3.
Lee M, Heo K, Lee S, Ah Y, Shin J, Lee J
Arch Gerontol Geriatr
. 2024 Feb;
120:105332.
PMID: 38382232
Background: Older adults are at an increased risk of acute kidney injury (AKI), particularly in community settings, often due to medications. Effective prevention hinges on identifying high-risk patients, yet existing...
4.
Geum M, Yu Y, Jeon J, Lee H, Shin J, Chung W, et al.
Thromb Res
. 2023 Dec;
233:127-134.
PMID: 38041878
Introduction: The efficacy of intracoronary (IC) antithrombotic therapy, which may best prevent the no-reflow phenomenon during percutaneous coronary intervention (PCI), remains unclear. Therefore, we compared the efficacy and safety of...
5.
Hahn J, Jeon J, Geum M, Lee H, Shin J, Chung W, et al.
Thromb J
. 2023 Jul;
21(1):76.
PMID: 37452333
Background: Intracoronary (IC) administration of glycoprotein IIb/IIIa inhibitors (GPIs) has been studied as an adjunctive therapy to improve outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary...
6.
Jung M, Lee B, Lee S, Shin J
Thromb Res
. 2023 Apr;
226:61-68.
PMID: 37121013
Introduction: As direct-acting oral anticoagulants (DOACs) have short half-lives of around 12 h, even a short gap in DOAC therapy may diminish anticoagulation effects, increasing risks of adverse clinical outcomes....
7.
Jun K, Ah Y, Shin J, Lee J
Age Ageing
. 2023 Mar;
52(3).
PMID: 36861184
Background: the identification and minimization of hyponatraemia-inducing medication (HIM) usage is among the effective strategies for preventing hyponatraemia. However, the differential risk of severe hyponatraemia is unknown. Objective: to evaluate...
8.
Lee S, Heo K, Lee M, Ah Y, Shin J, Lee J
Br J Clin Pharmacol
. 2023 Feb;
89(7):2216-2223.
PMID: 36807272
Aims: Few studies have quantified the impact of risk factors on GI complications in elderly nonsteroidal anti-inflammatory drug (NSAID) users. This study aimed to develop and validate a risk prediction...
9.
Knueppel P, Bang S, Troyer C, Barriga A, Shin J, Cadiz C, et al.
Thromb Res
. 2022 Oct;
220:91-96.
PMID: 36306678
Background: There are no clear dosing recommendations when using apixaban for venous thromboembolism (VTE) treatment in patients with severe or end-stage renal disease; clinical trials excluded patients with a creatinine...
10.
Hahn J, Jo Y, Yoo S, Shin J, Yu Y, Ah Y
Front Pharmacol
. 2022 Oct;
13:1009950.
PMID: 36304170
The use of opioid-gabapentinoid combinations has increased, raising several safety concerns. However, meta-analysis studies focusing on this issue are limited. To evaluate the risk of central nervous system (CNS) depression,...